Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
599.17B
Market cap599.17B
Price-Earnings ratio
40.01
Price-Earnings ratio40.01
Dividend yield
2.00%
Dividend yield2.00%
Average volume
8.11M
Average volume8.11M
High today
$259.46
High today$259.46
Low today
$245.19
Low today$245.19
Open price
$254.61
Open price$254.61
Volume
16.64M
Volume16.64M
52 Week high
$281.07
52 Week high$281.07
52 Week low
$184.66
52 Week low$184.66

Stock Snapshot

With a market cap of 599.17B, Johnson & Johnson(JNJ) trades at $249.15. The stock has a price-to-earnings ratio of 40.01 and currently yields dividends of 2.00%.

As of 2026-10-14, Johnson & Johnson(JNJ) stock has fluctuated between $245.19 and $259.46. The current price stands at $249.15, placing the stock +1.6% above today's low and -4.0% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 16.64M, compared to an average daily volume of 8.11M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

JNJ News

TipRanks 5h
Johnson & Johnson Earnings Call: Growth Amid Headwinds

Johnson & Johnson ((JNJ)) has held its Q3 earnings call. Read on for the main highlights of the call. Johnson & Johnson’s latest earnings call struck a cautious...

Axios 5h
Mike Johnson's Latino voter problem keeps getting worse - Axios

...

Mike Johnson's Latino voter problem keeps getting worse - Axios
The Motley Fool 8h
Stock Market Today, Oct. 13: Markets Edge Lower as Earnings Season Kicks Off

The S&P 500 (^GSPC -0.02%) slipped 0.02% to 7,805, remaining near record levels as investors parsed the first major batch of corporate results. The Nasdaq Compo...

Stock Market Today, Oct. 13: Markets Edge Lower as Earnings Season Kicks Off

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

Benzinga 10h
QUICK SPARK: J&J Eyes Worst Day Since April 2025 with MedTech Miss

Johnson & Johnson (NYSE:JNJ) beat profit estimates and raised its full-year forecast on Tuesday. The stock is still heading for its worst day in more than 18 mo...

QUICK SPARK: J&J Eyes Worst Day Since April 2025 with MedTech Miss
TipRanks 11h
Why SpaceX and J&J Stocks Are Falling Today — and What Wall Street Sees Next

Two Wall Street heavyweights are having a painful Tuesday, although their troubles have little in common. SpaceX (NASDAQ:SPCX) is sliding nearly 4% amid a broad...

Benzinga 12h
Chip Stocks Slide as South Korea's KOSPI Plunges, J&J Sinks 6%: Stock Market Today

U.S. stocks slipped by midday Tuesday as a chip-sector rout — sparked by a 5% plunge in South Korea’s KOSPI — offset gains in banks and energy, with the S&P 500...

Chip Stocks Slide as South Korea's KOSPI Plunges, J&J Sinks 6%: Stock Market Today
The Motley Fool 12h
Why Johnson & Johnson Stock Dropped Today

Johnson & Johnson (JNJ -6.96%) stock tumbled 6.8% through 12:30 p.m. ET Tuesday despite delivering an earnings beat this morning and raising guidance for the re...

Why Johnson & Johnson Stock Dropped Today
The Wall Street Journal 12h
Health Care Roundup: Market Talk

Brendan Mcdermid / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50...

Health Care Roundup: Market Talk
24/7 Wall St. 13h
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff

Investing Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff A raised full-year out...

Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff
Benzinga 13h
Johnson & Johnson Warns New Drug Deals Will Hit 2027 Earnings

Johnson & Johnson (NYSE:JNJ) on Tuesday reported third-quarter 2026 results that beat Wall Street estimates. The company also raised its full-year sales and adj...

Johnson & Johnson Warns New Drug Deals Will Hit 2027 Earnings

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.